Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Kazuhiro Yanagihara
Kenichi Yoshimura
Miyuki Niimi
Hiroyasu Yasuda
Takahiko Sasaki
Takafumi Nishimura
Hiroshi Ishiguro
Shigemi Matsumoto
Toshiyuki Kitano
Masashi Kanai
Akiko Misawa
Harue Tada
Satoshi Teramukai
Tadashi Mio
Masanori Fukushima
机构：
[1] Kyoto University Hospital,Outpatient Oncology Unit
[2] Kyoto University,Department of Translational Clinical Oncology, Graduate School of Medicine
[3] Kyoto University Hospital,Department of Clinical Trial Design and Management, Translational Research Center
[4] Kyoto University,Department of Multidisciplinary Cancer Treatment, Graduate School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Non-small cell lung cancer; Phase II study; Docetaxel; S-1; Second-line chemotherapy; Third-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：913 / 918
页数：5
相关论文
共 50 条
  • [31] Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer
    Bergqvist, Michael
    Holgersson, Georg
    Bondarenko, Igor
    Grechanaya, Elena
    Maximovich, Alexey
    Andor, Gyorgy
    Klockare, Maria
    Thureson, Marcus
    Jerling, Markus
    Harmenberg, Johan
    ACTA ONCOLOGICA, 2017, 56 (03) : 441 - 447
  • [32] A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancer
    Lee, Jae Jin
    Han, Ji-Youn
    Lee, Dae Ho
    Kim, Hyae Young
    Chun, Jong Ho
    Lee, Hong Gi
    Yoon, Seong Min
    Lee, Sung Young
    Lee, Jin Soo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (12) : 761 - 767
  • [33] Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer
    Takiguchi, Yuichi
    Tada, Yuji
    Gemma, Akihiko
    Kudoh, Shoji
    Hino, Mitsunori
    Yoshimori, Kozo
    Yoshimura, Akinobu
    Nagao, Keiichi
    Niitani, Hisanobu
    LUNG CANCER, 2010, 68 (03) : 409 - 414
  • [34] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [35] Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
    Hasegawa, Tsukasa
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Kudo, Keita
    Horiike, Atsushi
    Tambo, Yuichi
    Nishikawa, Shingo
    Ariyasu, Ryo
    Uchibori, Ken
    Kitazono, Satoru
    Nishio, Makoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 507 - 514
  • [36] Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
    Tsukasa Hasegawa
    Noriko Yanagitani
    Fumiyoshi Ohyanagi
    Keita Kudo
    Atsushi Horiike
    Yuichi Tambo
    Shingo Nishikawa
    Ryo Ariyasu
    Ken Uchibori
    Satoru Kitazono
    Makoto Nishio
    International Journal of Clinical Oncology, 2021, 26 : 507 - 514
  • [37] Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)
    Komiyama, K.
    Kobayashi, K.
    Minezaki, S.
    Kotajima, F.
    Sutani, A.
    Kasai, T.
    Mori, K.
    Hoshi, E.
    Takayanagi, N.
    Koyama, S.
    Eguchi, K.
    Nakayama, M.
    Kikuchi, K.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1474 - 1480
  • [38] Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)
    K Komiyama
    K Kobayashi
    S Minezaki
    F Kotajima
    A Sutani
    T Kasai
    K Mori
    E Hoshi
    N Takayanagi
    S Koyama
    K Eguchi
    M Nakayama
    K Kikuchi
    British Journal of Cancer, 2012, 107 : 1474 - 1480
  • [39] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Yoshikazu Hasegawa
    Isamu Okamoto
    Ken Takezawa
    Masaaki Miyazaki
    Junji Tsurutani
    Kimio Yonesaka
    Ryotaroh Morinaga
    Asuka Tsuya
    Masaaki Terashima
    Toshihiro Kudoh
    Koichi Azuma
    Takayasu Kurata
    Tatsuyuki Nishikawa
    Masahiro Fukuoka
    Yasumasa Nishimura
    Kazuhiko Nakagawa
    Investigational New Drugs, 2013, 31 : 599 - 604
  • [40] Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
    Tamura, Kenji
    Okamoto, Isamu
    Ozaki, Tomohiro
    Kashii, Tatsuhiko
    Takeda, Koji
    Kobayashi, Masashi
    Matsui, Kaoru
    Shibata, Takashi
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    Fukuoka, Masahiro
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) : 2132 - 2137
12345